Brief Growth Ideas: Aequitas: Raajmarg InvIT IPO - Stable Assets in a Small Portfolio, but Limited Immediate Appeal and more
In this briefing: Aequitas: Raajmarg InvIT IPO - Stable Assets in a Small Portfolio, but Limited Immediate Appeal Suzhou Genhouse Bio (勤浩医药) Pre-IPO: Moderate Innovation, Capped by Combination Economics Primer: Gateway Distriparks (GDPL IN) - Mar 2026 Aequitas: Ringpai Vet Hospital Pre-IPO- The Negatives- Supplier Concentration in a Fragmented Market Oil futures: Crude higher despite IEA strategic stocks release plan 1. Aequitas: Raajmarg InvIT IPO - Stable Assets in a Small Portfolio, but Limited Immediate Appeal Raajmarg Infra Investment Trust (RIIT IN) is planning to raise about US$652m through its India IPO. RIIT owns and manages a portfolio of five highway assets in India spread across six cities, like Tamil Nadu, Karnataka, Jharkhand, and Andhra Pradesh, as per the CARE Industry Report. In this note, we talk about the company’s historical performance, peer comparison and IPO valuations. 2. Suzhou Genhouse Bio (勤浩医药) Pre-IPO: Moderate Innovation, Capped by Combination Economics Suzhou Genhouse Bio, a China-based biotech, is looking to raise at least USD100m via a Hong Kong listing.